There was a great turnout at Biomedical Valley 2025, held in Mirandola, the heart of the
Italian biomedical district. This moment of strategic interaction brought together leading figures in life sciences — medtech, pharma, biotech companies and CROs — around the key topics of innovation,
regulation, and multilingual communication.
Mirandola: An Evolving Biomedical Ecosystem
The Mirandola district has been confirmed as one of the main European hubs for medical devices and healthcare technology.
The recent event clearly illustrated the urgent need for language solutions suitable for meeting
regulatory requirements (MDR, ISO 13485), the speed requested for clinical trials, and the need to
standardize technical and scientific communication in multiple languages.
Yellow Hub’s Contribution
Present at the event as a specialized language partner in the life sciences sector and ISO 13485 certified,
we had the opportunity to interact with regulatory affairs managers, QA directors, clinical trial
managers, and technical writers with some of the most innovative companies in Italian biomedicine.
We shared our solutions for:
- Certified translations complying with EMA and MDR requirements
- Automating document flows using CAT tools and customized TMSs
- Language validation for multicentre clinical trials
- Centralized management of glossaries, translation memories, and specific terminology
Feedback
Our direct interaction with industry professionals confirmed that significant attention is paid to
suppliers who can guarantee not only precision and conformity, but also efficiency, transparency, and speed.
Our integrated platform sparked interest for its capacity to track every stage of the translation
cycle and improve collaboration between technical, regulatory, and language teams.
Looking Towards the Future
The event in Mirandola was an important moment for listening. We will continue to invest in vertical
solutions for the biomedical sector, reinforcing our presence as a language partner of reference
for the district.
The opportunities emerging from Biomedical Valley 2025 will guide our activities in the coming
months, starting with new partnerships with local companies.
